Protalix Biotherapeutics shares owned by Capital Performance Advisors
Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by Capital Performance Advisors
from 13F filings
Historical chart of Capital Performance Advisors investment in Protalix Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Protalix Biotherapeutics held by Capital Performance Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv

Quarterly reported holdings in Protalix Biotherapeutics by Capital Performance Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-12-31 | $49k | 26k | 1.88 |
2024-09-30 | $27k | 26k | 1.02 |
2024-06-30 | $31k | 27k | 1.17 |
2024-03-31 | $33k | 26k | 1.26 |
2023-12-31 | $46k | 26k | 1.78 |
2023-09-30 | $43k | 26k | 1.66 |
2023-06-30 | $52k | 26k | 2.00 |
2023-03-31 | $55k | 26k | 2.10 |
2022-12-31 | $36k | 26k | 1.37 |
2022-09-30 | $27k | 26k | 1.04 |
2022-06-30 | $28k | 26k | 1.08 |
More positions owned by Capital Performance Advisors
View all positions for Capital Performance Advisors